Press release
Congestive Heart Failure (CHF) Market Report 2026 Market Outlook Supported By A Forecast 6.8% CAGR
Congestive Heart Failure (CHF) Market
Projected Market Value Growth in the Congestive Heart Failure Market
The congestive heart failure market is set to experience robust growth, reaching an estimated value of $23.79 billion by 2030. This corresponds to a compound annual growth rate (CAGR) of 6.8%. Several factors contribute to this upward trajectory, including a rising prevalence of heart failure, enhanced diagnostic methods, expansion of homecare services, increased use of guideline-driven therapies, and efforts to reduce hospital readmissions. Trends expected to influence the market during the forecast period encompass greater adoption of combination drug therapies, a move toward home-based management of heart failure, emphasis on early diagnosis and patient monitoring, increased investment in chronic disease management programs, and the growth of comprehensive post-discharge care pathways.
The congestive heart failure (chf) market size has grown strongly in recent years. It will grow from $17.1 billion in 2025 to $18.31 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to aging population growth, high prevalence of cardiovascular disease, limited outpatient monitoring options, frequent hospital readmissions, dependence on hospital-based care.
Download a free sample of the congestive heart failure (chf) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20730&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Top Companies Steering the Congestive Heart Failure Market Forward
The congestive heart failure market is dominated by several leading organizations, including Pfizer Inc., Johnson & Johnson Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Medtronic Plc, Canon Medical Systems Corporation, Jarvik Heart Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, LivaNova Plc, Edwards Lifesciences Corporation, Getinge AB, MicroPort Scientific Corporation, Lepu Medical Technology Co Ltd, OSCOR Inc., and Shree Pacetronix Ltd.
Strategic Acquisitions Enhancing Cardiovascular Treatment Portfolios
In October 2024, Johnson & Johnson, a US-based pharmaceutical giant, expanded its MedTech capabilities by acquiring V-Wave Ltd., an Israel-based company specializing in innovative therapies for congestive heart failure. This acquisition, for an undisclosed sum, strengthens Johnson & Johnson's presence in cardiovascular care by adding the Ventura Interatrial Shunt to its product portfolio, targeting heart failure treatment with novel technology.
View the full congestive heart failure (chf) market report:
https://www.thebusinessresearchcompany.com/report/congestive-heart-failure-chf-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Innovations Highlighting New Directions in Congestive Heart Failure Management
Prominent market players are focusing on cutting-edge therapies like single intracoronary infusion treatments, which deliver medication directly into the coronary arteries to improve heart function and patient quality of life. For instance, in January 2024, Bayer AG from Germany and US biotechnology firm Asklepios Biopharmaceutical, Inc. launched the GenePHIT Phase II clinical trial for AB-1002, a gene therapy designed to treat congestive heart failure. This trial, which is adaptive, double-blind, and placebo-controlled, targets patients with non-ischemic cardiomyopathy and involves enrolling 90 to 150 medically stable participants with left ventricular ejection fractions ranging between 15% and 35%.
Segment Overview Driving Growth in the Congestive Heart Failure Market
The report categorizes the congestive heart failure market into the following critical segments:
1) By Type: Systolic Heart Failure, Diastolic Heart Failure, Left-Sided Heart Failure, Right-Sided Heart Failure
2) By Treatment: Medication, Surgery
3) By Diagnosis: Electrocardiogram, Echocardiogram, Magnetic Resonance Imaging (MRI), Stress Test, Blood Tests, Cardiac Catheterization, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare Settings
Subsegment Details
Within these broader categories, subsegments include:
- Systolic Heart Failure divided into Reduced Ejection Fraction (HFrEF) and Mild-to-moderate Reduced Ejection Fraction
- Diastolic Heart Failure split into Preserved Ejection Fraction (HFpEF) and Borderline Ejection Fraction (HFpEF)
- Left-Sided Heart Failure covering Acute and Chronic forms
- Right-Sided Heart Failure also segmented into Acute and Chronic conditions
This comprehensive classification helps to understand the various facets influencing market dynamics and patient management approaches.
New strategic additions in our 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Congestive Heart Failure (CHF) Market Report 2026 Market Outlook Supported By A Forecast 6.8% CAGR here
News-ID: 4606193 • Views: …
More Releases from The Business Research Company
Coronary Pressure Market Report Examines Leading Companies And Growth Opportunit …
The coronary pressure market is positioned to experience significant expansion over the coming years, driven by technological advancements and shifting healthcare priorities. As cardiac care evolves with a greater emphasis on prevention and remote monitoring, this sector is set to witness notable progress. Below, we explore the market size projections, leading industry players, current influential trends, and detailed segmentation of the coronary pressure market.
Projected Market Size and Growth in the…
Corneal Topographers Market Outlook Highlights Strategic Opportunities Across Th …
The corneal topographers market is positioned for substantial expansion in the coming years, driven by numerous technological and clinical advancements. This market's growth reflects the increasing demand for precise eye diagnostics and improved patient care in ophthalmology. Let's explore the market's size, key players, trends, and segment details to gain a clearer understanding of its future trajectory.
Corneal Topographers Market Size Forecast and Growth Drivers
Valued at $1.25 billion by…
Cordyceps Sinensis Market Study Explores Industry Growth Toward $2.14 Billion
The Global Cordyceps Sinensis Market: Growth and Developments
The cordyceps sinensis market is set to experience significant expansion over the coming years, driven by various industry and consumer trends. As interest in natural health products and wellness continues to grow worldwide, this market is positioned to reach impressive milestones by the end of the decade. The following sections dive into market size projections, key players, evolving trends, and segmentation that define…
Contrast Therapy Equipment Market Research Reveals Path To $2.56 Billion By 2030
The contrast therapy equipment market is on the brink of significant expansion, fueled by growing interest in advanced rehabilitation and recovery technologies. As healthcare continues to prioritize personalized and home-based care, the demand for these specialized devices is expected to climb steadily. Below, we explore market size projections, key players, and emerging trends shaping this evolving industry.
Steady Surge in Contrast Therapy Equipment Market Size Through 2030
The contrast therapy…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
